Abbreviated DAPT regimen more beneficial to women compared to men: JAMA Medha Baranwal28 Nov 2023 11:30 AM ISTSwitzerland: A recent study published in JAMA Cardiology suggests that women with high bleeding risk (HBR) did not experience higher rates of bleeding...
DAPT de-escalation, short-term DAPT, best strategies for patients with acute coronary syndromes Medha Baranwal12 Sept 2023 10:15 AM ISTUSA: A recent network meta-analysis published in AHA Circulation Cardiovascular Interventions by Kuno T and colleagues has shed light on the optimal...
ESC 2023 Update: Dual-antiplatelet therapy should remain standard strategy after stent implantation Dr. Kamal Kant Kohli28 Aug 2023 9:45 AM ISTPrasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for...
Very short duration of DAPT well tolerated and feasible after coronary interventions Medha Baranwal28 Dec 2022 8:00 PM ISTGreece: The very short duration of dual antiplatelet therapy (VSDAPT) of less than three months could be feasible and well tolerated after PCI...
No antithrombotic therapy okay for select TAVR patients: Data from OCEAN-TAVI Registry Medha Baranwal16 Dec 2022 10:30 AM ISTJapan: In selected patients with transcatheter aortic valve replacement (TAVR), the nonantithrombotic strategy may be an acceptable alternative to...
Nuisance bleeding tied to early increase in bleeding risk in patients with acute MI on DAPT: Circulation Medha Baranwal5 Dec 2022 10:15 AM ISTKorea: A subanalysis of the TALOS-AMI trial has shown nuisance bleeding (NB) to be frequent in patients with acute myocardial infarction (AMI) on...
Following DAPT cessation, P2Y12 inhibitors better than aspirin for monotherapy, JACC analysis. dr. Abhimanyu Uppal2 Nov 2022 12:15 PM ISTOver past few years, there has been upcoming literature supporting shorter duration DAPT regimens following PCI. But what remains unknown is which...
DAPT with ticagrelor and aspirin combo reduces saphenous vein graft failure in CABG: JAMA Dr.Niharika Harsha B16 Aug 2022 11:00 AM ISTRecent research published in the JAMA Network found that Ticagrelor added to Aspirin was associated with a significantly decreased risk of vein graft...
One month DAPT good enough in complex PCI patients with high bleeding risk Medical Dialogues Editorial Team21 May 2022 9:45 AM ISTSwitzerland: High bleeding risk patients who have undergone percutaneous coronary intervention (PCI), 1 month of dual antiplatelet therapy (DAPT) was...
Cilostazol effective drug in preventing stroke in men than women Dr. Nandita Mohan26 March 2022 5:30 PM ISTDual antiplatelet therapy (DAPT) is highly effective in preventing atherothrombotic complications in patients with previous myocardial infarction and...
Short DAPT Followed by Clopidogrel monotherapy No Better Than Long term DAPT: JAMA MD Bureau3 March 2022 11:00 AM ISTPatients with Acute Coronary Syndrome (ACS) are regarded as having a higher long-term risk of cardiovascular events after percutaneous coronary...
Dual Antiplatelet therapy much efficient in treating Cardiovascular death: MASTER DAPT Trial MD Editorial Team10 Feb 2022 9:00 AM ISTCardiac death is greater burden on global health. Fatal heart diseases involve formation of clots in major blood vessels, antiplatelet medicines can...
